SE415143B - Sett att framstella en stabil emulsion av en organisk fluorforening, avsedd att anvendas bl a som artificiellt blod - Google Patents
Sett att framstella en stabil emulsion av en organisk fluorforening, avsedd att anvendas bl a som artificiellt blodInfo
- Publication number
- SE415143B SE415143B SE650072A SE650072A SE415143B SE 415143 B SE415143 B SE 415143B SE 650072 A SE650072 A SE 650072A SE 650072 A SE650072 A SE 650072A SE 415143 B SE415143 B SE 415143B
- Authority
- SE
- Sweden
- Prior art keywords
- emulsion
- water
- fluorocarbon
- polyoxyethylene
- particles
- Prior art date
Links
- 239000000839 emulsion Substances 0.000 title claims description 74
- 239000002473 artificial blood Substances 0.000 title claims description 7
- 239000000126 substance Substances 0.000 title claims 2
- 125000001153 fluoro group Chemical class F* 0.000 title 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 claims description 41
- 239000002245 particle Substances 0.000 claims description 38
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 239000002736 nonionic surfactant Substances 0.000 claims description 17
- -1 polyoxyethylene Polymers 0.000 claims description 15
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 claims description 13
- 239000004359 castor oil Substances 0.000 claims description 12
- 235000019438 castor oil Nutrition 0.000 claims description 12
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 150000005846 sugar alcohols Polymers 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 238000010438 heat treatment Methods 0.000 claims description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 8
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 8
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000811 xylitol Substances 0.000 claims description 8
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 8
- 229960002675 xylitol Drugs 0.000 claims description 8
- 235000010447 xylitol Nutrition 0.000 claims description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 230000005484 gravity Effects 0.000 claims description 4
- 239000007764 o/w emulsion Substances 0.000 claims description 4
- 150000004812 organic fluorine compounds Chemical class 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 230000010412 perfusion Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000011160 research Methods 0.000 claims description 3
- 238000002054 transplantation Methods 0.000 claims description 3
- 210000001835 viscera Anatomy 0.000 claims description 3
- 239000003633 blood substitute Substances 0.000 claims description 2
- 150000002222 fluorine compounds Chemical class 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- 238000003860 storage Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 10
- 238000002347 injection Methods 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 238000004062 sedimentation Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000004215 Carbon black (E152) Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 229930195733 hydrocarbon Natural products 0.000 description 4
- 150000002430 hydrocarbons Chemical class 0.000 description 4
- 239000007791 liquid phase Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 3
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 3
- 229910000397 disodium phosphate Inorganic materials 0.000 description 3
- 235000019800 disodium phosphate Nutrition 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- RVZRBWKZFJCCIB-UHFFFAOYSA-N perfluorotributylamine Chemical compound FC(F)(F)C(F)(F)C(F)(F)C(F)(F)N(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F RVZRBWKZFJCCIB-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229950011087 perflunafene Drugs 0.000 description 2
- UWEYRJFJVCLAGH-IJWZVTFUSA-N perfluorodecalin Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)[C@@]2(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)[C@@]21F UWEYRJFJVCLAGH-IJWZVTFUSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 description 1
- QZFIQARJCSJGEG-UHFFFAOYSA-N 1,1,1,2-tetrafluoro-2-(1,2,2,2-tetrafluoroethoxy)ethane Chemical compound FC(F)(F)C(F)OC(F)C(F)(F)F QZFIQARJCSJGEG-UHFFFAOYSA-N 0.000 description 1
- LWRNQOBXRHWPGE-UHFFFAOYSA-N 1,1,2,2,3,3,4,4,4a,5,5,6,6,7,7,8,8a-heptadecafluoro-8-(trifluoromethyl)naphthalene Chemical compound FC1(F)C(F)(F)C(F)(F)C(F)(F)C2(F)C(C(F)(F)F)(F)C(F)(F)C(F)(F)C(F)(F)C21F LWRNQOBXRHWPGE-UHFFFAOYSA-N 0.000 description 1
- VINLJJIHDWAANV-UHFFFAOYSA-N 1,1,2,3,3,3-hexafluoro-2-[1,1,2,3,3,3-hexafluoro-2-[1,1,2,3,3,3-hexafluoro-2-(1,1,2,2,3,3,3-heptafluoropropoxy)propoxy]propoxy]propan-1-ol Chemical compound OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(C(F)(F)F)OC(F)(F)C(F)(F)C(F)(F)F VINLJJIHDWAANV-UHFFFAOYSA-N 0.000 description 1
- PQMAKJUXOOVROI-UHFFFAOYSA-N 2,2,3,3,5,5,6,6-octafluoro-4-(trifluoromethyl)morpholine Chemical compound FC(F)(F)N1C(F)(F)C(F)(F)OC(F)(F)C1(F)F PQMAKJUXOOVROI-UHFFFAOYSA-N 0.000 description 1
- VHCKLBQLRHKFJW-UHFFFAOYSA-N 2,3,4-trifluoro-5-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)furan Chemical compound FC=1OC(C(F)(F)C(F)(F)C(F)(F)C(F)(F)F)=C(F)C=1F VHCKLBQLRHKFJW-UHFFFAOYSA-N 0.000 description 1
- FYYLCPPEQLPTIQ-UHFFFAOYSA-N 2-[2-(2-propoxypropoxy)propoxy]propan-1-ol Chemical compound CCCOC(C)COC(C)COC(C)CO FYYLCPPEQLPTIQ-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000208202 Linaceae Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001993 poloxamer 188 Polymers 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- PXXNTAGJWPJAGM-UHFFFAOYSA-N vertaline Natural products C1C2C=3C=C(OC)C(OC)=CC=3OC(C=C3)=CC=C3CCC(=O)OC1CC1N2CCCC1 PXXNTAGJWPJAGM-UHFFFAOYSA-N 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- External Artificial Organs (AREA)
- Colloid Chemistry (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3391171 | 1971-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE415143B true SE415143B (sv) | 1980-09-15 |
Family
ID=12399686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE650072A SE415143B (sv) | 1971-05-19 | 1972-05-18 | Sett att framstella en stabil emulsion av en organisk fluorforening, avsedd att anvendas bl a som artificiellt blod |
Country Status (6)
| Country | Link |
|---|---|
| CA (1) | CA942191A (enExample) |
| CH (1) | CH598748A5 (enExample) |
| DE (1) | DE2224182C2 (enExample) |
| FR (1) | FR2157774B1 (enExample) |
| GB (1) | GB1343870A (enExample) |
| SE (1) | SE415143B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3911138B1 (en) * | 1973-02-26 | 1996-10-29 | Childrens Hosp Medical Center | Artificial blood and method for supporting oxygen transport in animals |
| IT1050731B (it) * | 1974-12-09 | 1981-03-20 | Childrens Hosp Medical Center | Composti perfluoropoliciclici per l impiego come sangue sintetico e ambiente di ferfusione |
| US4163734A (en) * | 1975-05-30 | 1979-08-07 | Radiometer A/S | Reference liquid for blood gas equipment |
| US4116336A (en) * | 1975-05-30 | 1978-09-26 | Radiometer A/S | Package containing a reference liquid for blood gas equipment |
| US4151108A (en) * | 1976-01-27 | 1979-04-24 | Radiometer A/S | Reference liquid for blood gas equipment |
| US4369127A (en) * | 1980-07-21 | 1983-01-18 | Instrumentation Laboratory Inc. | Blood gas control |
| US4299728A (en) * | 1980-07-21 | 1981-11-10 | Instrumentation Laboratory Inc. | Blood gas control |
| IT1229222B (it) * | 1989-03-31 | 1991-07-26 | Ausimont Srl | Emulsioni stabili di perfluoropolieteri |
| CN116672910A (zh) * | 2023-07-03 | 2023-09-01 | 昌正健康护理(盐城)有限公司 | 一种化学品生产用乳化设备及其乳化工艺 |
-
1972
- 1972-05-11 GB GB2203572A patent/GB1343870A/en not_active Expired
- 1972-05-12 FR FR7216962A patent/FR2157774B1/fr not_active Expired
- 1972-05-12 CA CA141,990A patent/CA942191A/en not_active Expired
- 1972-05-18 CH CH739072A patent/CH598748A5/xx not_active IP Right Cessation
- 1972-05-18 SE SE650072A patent/SE415143B/sv unknown
- 1972-05-18 DE DE19722224182 patent/DE2224182C2/de not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA942191A (en) | 1974-02-19 |
| DE2224182A1 (de) | 1972-12-21 |
| FR2157774A1 (enExample) | 1973-06-08 |
| CH598748A5 (enExample) | 1978-05-12 |
| DE2224182C2 (de) | 1987-01-22 |
| GB1343870A (en) | 1974-01-16 |
| FR2157774B1 (enExample) | 1976-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU614173B2 (en) | Hemoglobin multiple emulsion | |
| EP0231091B1 (en) | Stable emulsions of highly fluorinated organic compound | |
| US3823091A (en) | Stable emulsion of fluorocarbon particles | |
| EP0449825B1 (en) | Improved emulsions of highly fluorinated organic compounds | |
| EP0627913B1 (en) | Facilitated oxygen delivery in conjunction with hemodilution | |
| AU706236B2 (en) | Stable reverse and multiple fluorocarbon emulsions | |
| CA1042799A (en) | Perfluorocyclocarbons as gas transport agents in animals | |
| FR2679150A1 (fr) | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. | |
| US3958014A (en) | Process for preparing injection-purpose fluorocarbon emulsion capable of carrying oxygen | |
| JP2003502363A (ja) | プロポフォールを含有する静脈内注射用麻酔剤組成物 | |
| HK1010448B (en) | Facilitated oxygen delivery in conjunction with hemodilution | |
| SE415143B (sv) | Sett att framstella en stabil emulsion av en organisk fluorforening, avsedd att anvendas bl a som artificiellt blod | |
| JPS5835485B2 (ja) | 酸素運搬輸液 | |
| RU2122404C1 (ru) | Способ получения эмульсии на основе перфторорганических соединений для медико-биологических целей | |
| RU2199311C2 (ru) | Состав перфторуглеродного кровезаменителя на основе эмульсии перфторорганических соединений для медико-биологических целей | |
| RU2200544C1 (ru) | Способ получения стерильных перфторуглеродных эмульсий для искусственных перфторуглеродных кровезаменителей | |
| EP0841896B1 (en) | Reverse gels comprising a continuous fluorinated phase | |
| RU2393849C2 (ru) | Эмульсия перфторорганических соединений медицинского назначения, способ ее приготовления и способ ее применения | |
| JPS6033367B2 (ja) | 酸素運搬輸液 | |
| GEYER | Surfactants and perfluorochemical emulsions for use in blood replacement preparations | |
| WO1995028146A1 (en) | Fluorochemical emulsions containing 1,3-dialkylglycerophosphoryl choline surfactants and methods of use | |
| JPS61289026A (ja) | 静脈注射用脂肪乳剤 | |
| KR810000695B1 (ko) | 산소 운반 가능한 플루오로카아본 유탁액의 제조방법 | |
| RU2308939C2 (ru) | Способ получения синтетических перфторуглеродных кровезаменителей и других сред на основе перфторуглеродных эмульсий | |
| MC2482A1 (fr) | Emulsions de fluorocarbures utilisables comme transporteurs d'oxygène dans les systèmes biologiques et contenant des carbamates fluorés biocompatibles comme additifs stabilisants |